Edition:
United Kingdom

Lotus Health Group Co (600186.SS)

600186.SS on Shanghai Stock Exchange

2.44CNY
14 Feb 2018
Change (% chg)

¥-0.16 (-6.15%)
Prev Close
¥2.60
Open
¥2.50
Day's High
¥2.57
Day's Low
¥2.40
Volume
55,033,804
Avg. Vol
17,472,620
52-wk High
¥5.15
52-wk Low
¥1.94

Chart for

About

Lotus Health Industry Holding Group Company, formerly HENAN LOTUS FLOWER GOURMET POWDER CO., LTD., is a China-based company primarily engaged in the production and distribution of monosodium glutamate and other flavoring products. The Company's principal products are monosodium glutamate under the brand named Lotus Flower. The... (more)
No analyst recommendations are available for .

Overall

Beta: 1.52
Market Cap(Mil.): ¥4,290.58
Shares Outstanding(Mil.): 1,062.02
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 22.59 16.60
EPS (TTM): -- -- --
ROI: -- 12.23 10.66
ROE: -- 15.61 14.30

BRIEF- Lotus Health Group sees 2017 net loss to be 100 mln yuan to 120 mln yuan

* Sees 2017 net loss to be 100 million yuan to 120 million yuan

29 Jan 2018

BRIEF-Lotus Health Group to invest 20 mln yuan to set up trade unit

* Says it will invest 20 million yuan to set up a wholly owned trade unit in Heilongjiang

24 Jan 2018

BRIEF-Lotus Health Group receives land compensation and subsidy of totalling 138.5 mln yuan

* Says it received land compensation and subsidy of totalling 138.5 million yuan as of Dec. 27

28 Dec 2017

BRIEF- Lotus Health Group says cancellation of stake transfer in two firms

* Says it cancels transfer of 100 percent stake in a thermal power unit and 43 percent stake in a sugar industry firm

08 Dec 2017

BRIEF-Lotus Health plans to sell thermal power unit for 244 mln yuan

* Says it plans to sell thermal power unit for 244.0 million yuan ($36.69 million)

29 Sep 2017

BRIEF-Regulator resumes review of Lotus Health's share private placement application

* Says securities regulator resumes review of its share private placement application

20 Sep 2017

BRIEF-Regulator halts review of Lotus Health's share private placement application

* Says securities regulator halts review of its share private placement application

23 Aug 2017

Earnings vs. Estimates

No consensus analysis data available.